Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

Rhea-AI Summary

Alpine Immune Sciences, Inc. (ALPN) to participate in H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference. Remy Durand, Chief Business Officer, to join fireside chat. Investor meetings scheduled. Webcasts and replays available on company website.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company will participate in the H.C. Wainwright 2^nd Annual Autoimmune & Inflammatory Disease Virtual Conference.

• Thursday, March 28^th, Remy Durand, Ph.D., Chief Business Officer at Alpine, will participate in a fireside chat at 3:00 pm ET/12:00 pm PT and the Company will host investor meetings the same day.

Live webcasts of the fireside chats will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, www.alpineimmunesciences.com visit. Follow @AlpineImmuneSci on X and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240320830092/en/

Media and Investor Relations:

ir@alpineimmunesciences.com

media@alpineimmunesciences.com

Source: Alpine Immune Sciences, Inc.

When will Alpine Immune Sciences, Inc. participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference?

Alpine Immune Sciences, Inc. will participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28th.

Who will join the fireside chat during the conference?

Remy Durand, Ph.D., Chief Business Officer at Alpine Immune Sciences, Inc., will join the fireside chat during the conference.

Where can investors watch the live webcasts of the fireside chats?

Investors can watch the live webcasts of the fireside chats on the investor relations section of Alpine Immune Sciences, Inc.'s website at https://ir.alpineimmunesciences.com/events.

How long will the replay of the webcasts be available?

The replay of the webcasts will be available on Alpine Immune Sciences, Inc.'s website for 90 days following the event.